C5AR1 and cardiomyopathy: Likewise, aberrant C5aR1 pathway activation can exacerbate myocardial injury in arrhythmogenic cardiomyopathies, as C5a–C5aR1 interactions recruit neutrophils and monocytes, promote tissue fibrosis, and enhance electrical instability.